![Peter Skorpil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Skorpil worked as a Commercial Director at Pronova BioPharma ASA, Manager-Business Development at Weifa ASA, and Vice President-Business Development at Circio Holding ASA. He holds an MBA from Brandeis University and a doctorate from the University of Geneva.
| Bedrijven | Functie | Einde |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Corporate Officer/Principal | - |
| WEIFA ASA | Corporate Officer/Principal | - |
| CIRCIO HOLDING ASA | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Manufactures non-prescription and over-the-counter pharmaceutical products | Health Technology |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
